Clinical trial · Observational
Investigation of the Effectiveness of CoronaVac Vaccine in Cancer Patients With Active Chemotherapy and Comparison With Healthy People.
NCT04765215CI-TRIAL-00052236unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aimed to investigate the effectiveness of CoronaVac vaccine, which is more than 90% protective in healthy people, in cancer patients receiving active chemotherapy. In this study, to collect information to measure the amount of antibodies produced by the vaccine in the blood of volunteers with the CoronoVac vaccine and to compare it with healthy volunteers.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Is the Coronovac Vaccine Effective in Patients Receiving Chemotherapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CoronoVAC | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Breast or lung cancer patients receiving active chemotherapy and 2 doses of CoronaVac vaccine
- interventionNames
- Biological: CoronoVAC
- label
- Healthy volunteers who received two doses of coronavac vaccine
- interventionNames
- Biological: CoronoVAC
Primary outcomes (1)
- measure
- Antibody levels above the defined cut-off
- timeFrame
- Between the third and sixth weeks after the second dose of vaccine
- description
- SARS-CoV-2 IgG II ≥ 50.0 AU/ml (positive) and SARSCoV- 2 IgM \>1 (positive)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * Group 1 1. 18 years old and above 2. Having completed two doses of CoronoVac vaccine on time 3. Those with a pathological diagnosis of breast cancer or lung cancer 4. Being the first dose of vaccine during active chemotherapy period 5. Ecog performance score 0-1 6. Patients who signed the informed voluntary consent form * Group 2 1. Over 18 years old 2. Ecog performance score is 0-1 3. Those who have completed 2 doses of coronovac vaccine within the recommended period 4. Volunteer who signed the informed consent form Exclusion Criteria: * For all groups 1. Being confirmed or suspected covid-19 before vaccination 2. Symptomatic covid-19 infection 3. Being addicted to alcohol or drugs 4. Having a fever of 37.8 ° C as a suspect before vaccination 5. Aspleni
References
Publications (0)
Data not yet available
No reference posted for this study.